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Background: In the last years, thousands of refugees have come to Norway and other Western
countries. However, mental health services for adults with ID and additional mental illnesses
within the migrant population is an understudied topic. Clinical experience indicates that
professionals struggle when providing services to adults with ID and additional mental health
issues in this population. Objectives: The objective of this study was to investigate the families’
experiences of mental health services for a family member with intellectual disability. In addi-
tion, we wanted to know if there is need for special adjustments in the assessment and treatment
of patients with ID in the migrant population. Methods: As this is an understudied topic, we
chose a qualitative approach. Three families and the patients’ residential caregivers were inter-
viewed. The interviews were taped, transcribed and consequently analysed. Results: The families
expressed that the employment of professional interpretation would have been an advantage
when communicating with mental health services. The professional lingua and psychiatric
diagnoses may be unknown, and it could be difficult to describe symptoms and difficulties
related to mental disorders, lacking specific language for such problems. The professional
caregivers supported the answers from the families. Conclusion: The findings in this pilot
study are in line with findings of studies examining mental health in the general migrant
population. Mental health services for adults with intellectual disability in the migrant popula-
tion must include the families.
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Background: The increase in defined genetic causes of intellectual disabilities (ID) creates the need for
instruments which differentiate between the level of functioning and syndrome-specific neurobehavioral
and cognitive characteristics. The present study investigates the use of four simplified tablet-based
neuropsychological test (CANTAB) and a semi-structured clinical observation (ADOS-2) in patients
with rare genetic syndromes who havemoderate to profound ID.Method: Inclusion comprised a biological
age above 3 years and a genetically confirmed causative monogenetic disorder resulting in ID. In total, 56
subjects participated. The Vineland Adaptive Behavior Scale interview was completed to calculate a

























(ADOS-2) and four simplified tasks of the Cambridge Neuropsychological Test Automated Battery
(CANTAB), the Motor Screening Test (MOT), Pattern Recognition Memory (PRM), the Intra-Extra
Dimensional Test Shift (IED), and Paired Associate Learning (PAL). Results: For the CANTAB, a cut-
off in the developmental age was defined at which test application was successful. Correlations were
assessed between test performance and subject characteristics. Overall performance was also measured for
ADOS-2, and specific factors within the ADOS-2 were distinguished for clinical importance. Discussion:
Our results indicate an additional value of using simplified CANTAB tasks and the ADOS-2 in the ID
population to differentiate between the level of ID and syndrome-specific neurobehavioral and cognitive
features. The results of these tests are helpful in diagnostic procedures, formulating personalized treatment
and guidance as well as to enhance specific knowledge about genetic syndromes.
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Aims: Calcifications of the basal ganglia (BGC) are observed in about 0.5–1.0% of routine computed
tomography brain (CT) scans. BGC can indicate a calcium metabolism disorder and may be
associated with a variety of psychiatric and neurological symptoms. In 22q11.2 deletion syndrome
(22q11.2DS), in addition to intellectual disability, there is an elevated lifetime risk of hypoparathyr-
oidism/hypocalcemia (~80%), psychiatric and neurologic manifestations, including psychotic dis-
orders (~25%), seizures (~40%), and movement disorders. The potential connections between these
manifestations are however poorly understood. Methods: To begin to address the potential effects of
BGC in 22q11.2DS, we reviewed lifetime medical records for relevant clinical data in individuals
with BGC from a well-characterized Canadian adult 22q11.2DS cohort (n = 286, median age
30.6 years; n = 86 with CT scan data). Results: Ten (11.6%) of 86 adults (6 male, 4 female; median
age 39 (24–57) years) with 22q11.2DS and CT data had BGC (6 bilateral, 1 unilateral, 3 unspecified),
detected at median age 22.5 (17–56) years. Although seizures were the most common known reason
for CT (4/8, 50%), there was a lifetime history in all 10 (100%) of psychotic disorder, 9 (90%) of
movement abnormalities (4 tremors, 4 tardive dyskinesia, 2 rigidity), and 8 (80%) of seizures. Nine
(90%) had a history of hypoparathyroidism/hypocalcemia. Conclusions: The results support an
association of 22q11.2DS with BGC, and the possibility that neurological and psychiatric features
may be particularly prevalent in these patients. Future studies are needed to understand how brain
calcification may relate to the neuropsychiatric phenotype of 22q11.2DS.
© 2017 Taylor & Francis
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